The connection between cancer response and autoimmune disease in the brain lies with the antibodies deployed to fight cancer.

UCB has achieved 15 FDA approvals or indication expansions, nine of which were secured in the past three years.

It is well known that chronic inflammation can increase a person’s cancer risk, but the underlying mechanisms remain unknown. Now, a new study reveals, in a mouse model of colitis, gut tissues may ...

Merck & Co. has agreed to acquire Terns Pharmaceuticals for approximately $6.7 billion, in a deal designed to bolster the buyer’s cancer pipeline with that of Terns—led by an oral tyrosine kinase ...

The newest production line at the Milford site represents the largest expansion in Rentschler Biopharma’s more than 150-year history.

X-Cell generalizes to new biological contexts and breaks barriers as the first scaling law demonstrator in the virtual cell domain.

There are three technical enablers “that repeatedly separate successful [AI] deployments from stalled pilots: trustworthy data pipelines, fit-for-purpose model selection, and lifestyle governance,” ...

AI is already helping the biopharmaceutical industry to optimize its manufacturing activities, according to IFPMA.

Scout-triggered mass spectrometry improves host-cell protein monitoring across diverse bioprocessing matrices in one ...

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

Whether Judge Murphy’s ruling holds through appeal will determine how much institutional credibility can be recovered.

Scientists suggest findings highlight potential targets and could lead to the development of therapies that specifically block the tumor’s ability to spread.